Kazia Therapeutics (KZIA) Other Non-Current Assets (2018 - 2025)
Kazia Therapeutics (KZIA) posted Other Non-Current Assets of $138207.8 for Q4 2025, down 56.01% on a QoQ basis from $314169.6 in Q2 2025, and down 14.18% year-over-year from $161035.5 in Q4 2024.
Kazia Therapeutics (KZIA) has 6 years of Other Non-Current Assets data on file, last reported at $138207.8 in Q4 2025.
- In Q4 2025, Other Non-Current Assets fell 14.18% year-over-year to $138207.8; the TTM figure through Dec 2025 stood at $138207.8 (down 14.18% YoY), while the FY2025 annual figure was $314169.6, down 19.36% from the prior year.
- Other Non-Current Assets retreated to $138207.8 in Q4 2025, from $314169.6 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.1 million in Q2 2023 and bottomed at $138207.8 in Q4 2025.
- A 3-year average of $425325.9 and a median of $351879.9 in 2024 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets tumbled 64.83% — and 2025, when it retreated 14.18%.
- Year by year, Other Non-Current Assets stood at $457872.2 in 2023, then plunged by 64.83% to $161035.5 in 2024, then dropped by 14.18% to $138207.8 in 2025.
- The last three Other Non-Current Assets figures came in at $138207.8 (Q4 2025), $314169.6 (Q2 2025), and $161035.5 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Kazia Therapeutics | 1.55 Bn | 1.55 Bn | - | 138,207.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138,207.84 |
| Jun 30, 2025 | 314,169.63 |
| Dec 31, 2024 | 161,035.50 |
| Jun 30, 2024 | 389,590.23 |
| Dec 31, 2023 | 457,872.20 |
| Jun 30, 2023 | 1.09 Mn |
| Dec 31, 2020 | 738,787.94 |
| Jun 30, 2020 | 352,160.78 |
| Dec 31, 2019 | 123,787.68 |
| Jun 30, 2019 | 258,897.35 |
| Dec 31, 2018 | 103,361.77 |
| Jun 30, 2018 | 581,369.53 |